Cannabis Shares Rocket After-Hours. Tilray up 13% After a 42% Rally in Regular Session; Canopy Growth up 8% After a 26% Rally

TigerAug 11, 2025 11:09 PM

View all comments（0）



Cannabis shares continued to jump in after-hours trading. Tilray up 13% after a 42% rally in regular session; Canopy Growth up over 26%; Aurora Cannabis, Cronos Group up 16%.

President Trump is considering reclassifying marijuana as a less dangerous drug, according to people familiar with the matter, after pot companies have poured millions of dollars into Trump’s political groups.

At a $1 million-a-plate fundraiser at his New Jersey golf club earlier this month, Trump told attendees that he was interested in change, the people, who declined to be named, said. Such a shift, which the Biden administration started pursuing but didn’t enact before leaving office, would make it much easier to buy and sell pot and make the multibillion-dollar industry more profitable.

The guests at Trump’s fundraiser included Kim Rivers, the chief executive of one of the largest marijuana companies, Trulieve, who encouraged Trump to pursue the change and expand medical marijuana research, according to people present at the event.

Trump listened and said he was interested, according to three people in the room. He flagged it to staff members there, the people said.

Among the other guests: Pfizer’s CEO, cryptocurrency executives and political advisers close to Trump. The group also discussed New York politics, attendees said, and requests from other donors.

The fundraiser conversation was part of a campaign by cannabis companies to persuade Trump to pick up where the Biden team left off and reclassify the drug. The companies have contributed millions to the president’s political groups and hired some of the Washington’s top lobbyists and advisers to Trump. The companies went to Trump directly after failing to gain traction across other agencies in the government.

The push centers on whether marijuana should be reclassified as a Schedule III drug, which wouldn’t make the drug entirely legal but would ease restrictions on it. It would also allow for tax breaks for some marijuana companies and additional medical research.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?

TradingKey - At the Connect 2026 conference held from September 23 to 24, Meta (META) unveiled the Ray-Ban Meta Audio, third-generation Ray-Ban Meta, and Meta VR Glasses, while upgrading the Meta Ray-Ban Display. The company also announced the integration of its personal AI agent, Muse, into its AI glasses, expanding its product scope from mobile phones and social apps to wearable devices.

Today’s Market Recap: 10-Year Treasury Yield Hits Highest Level Since 2007, Major U.S. Indexes Fall, SpaceX Drops Over 4%

TradingKey — Rising Treasury yields and oil prices weighed on U.S. equities, sending all three major indexes lower. On September 23, the 10-year Treasury yield climbed to its highest level since July 2007, while rebounding crude prices intensified concerns over inflation and interest rates. Technolo

Japan Stocks Open Higher After Three-Day Holiday, SoftBank Rises Over 6%, Kioxia Up Nearly 4%; South Korean Markets Closed

TradingKey - On September 24, Japanese stock markets resumed trading after a three-day holiday, with the Nikkei 225 Index (JPN225) opening 0.6% higher and later extending gains to 1.25% to reach 65,828.43 points. Meanwhile, South Korean stock markets were closed for a holiday.

【US Pre-Market】Nasdaq Leads Losses in Three Major Stock Index Futures, IONQ Surges Over 11%, RGTI Rises Over 5% as Market Focuses on US-China Summit

TradingKey - On Wednesday (September 23) Eastern Time, futures tied to the three major U.S. stock indexes edged up in pre-market trading. Diplomatic mediation in the Middle East and the restoration of a key Saudi oil pipeline kept international oil prices below $100 per barrel, temporarily easing energy inflation concerns. Meanwhile, investors are awaiting the summit between Chinese and U.S. leaders and the preliminary U.S. September PMI data, while a strengthening U.S. dollar and the risk of further Federal Reserve rate hikes continue to cap market gains.

The Week Ahead: US-China Summit in Washington, Costco Earnings and Fed Rate Path in Focus

TradingKey - During the week of September 21 to 25, Eastern Time, the US stock market will focus on the meeting between Chinese and US leaders, the Federal Reserve's policy outlook, and economic data such as US new home sales and durable goods orders.

Featured Tools